Extended adjuvant hormonal therapy with exemestane has no detrimental effect on the lipid profile of postmenopausal breast cancer patients: final results of the ATENA lipid substudy

INTRODUCTION: Extended adjuvant endocrine therapy for breast cancer with aromatase inhibitors may potentially alter the lipid profile of postmenopausal patients and thus increase the risk of developing cardiovascular disease. In this study, a subprotocol of the ATENA (Adjuvant post-Tamoxifen Exemest...

Descripción completa

Detalles Bibliográficos
Autores principales: Markopoulos, Christos, Dafni, Urania, Misitzis, John, Zobolas, Vasilios, Tzoracoleftherakis, Evagelos, Koukouras, Dimitrios, Xepapadakis, Grigorios, Papadiamantis, John, Venizelos, Basileios, Antonopoulou, Zoh, Gogas, Helen
Formato: Texto
Lenguaje:English
Publicado: BioMed Central 2009
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2716503/
https://www.ncbi.nlm.nih.gov/pubmed/19531217
http://dx.doi.org/10.1186/bcr2320

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2716503/
https://www.ncbi.nlm.nih.gov/pubmed/19531217
http://dx.doi.org/10.1186/bcr2320

Ejemplares similares